INTERNATIONAL PATENT: OSE IMMUNOTHERAPEUTICS FILES APPLICATION FOR "USES OF ANTI-CD127 ANTIBODIES IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASES"

GENEVA, Feb. 2 -- OSE IMMUNOTHERAPEUTICS (22, boulevard Benoni Goullin44200 NANTES) filed a patent application (PCT/EP2025/071163) for "USES OF ANTI-CD127 ANTIBODIES IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASES" on Jul 23, 2025. With publication no. WO/2026/022216, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): COSTANTINI, Dominique (22 boulevard Benoni Goullin44200 NANTES), CORALLO, Frederique (22 boulevard Benoni Goullin44200 NANTES)

Abstract: The application generally relates to the treatment of inflammatory bowel...